Thursday, December 6, 2012

Images

Catherine Twomey, 2006. Photo Google scholar
http://dels-old.nas.edu/bls/stemcells/images/Embryonic-Download.JPG

 Summary:The image is plurpotent cells
Ascess:I will be useing this image.
Reflect:I will be using this image in my slideshow
 Paul J. Tesar, 2006. Photo Google scholar
http://en.wikipedia.org/wiki/File:Humanstemcell.JPG
Summary: The image is of a human stem cell
Assess: The source is useful to go with my content in my slideshow
Reflect: I will be using the image in my slide show
 Zoey Huang, 2012. Photo Google Scholar
http://newscenter.berkeley.edu/2012/06/06/stem-cells-vascular-disease/
Summary: The source is actual researchers in a topic that I will be using in my slideshow.
Assess: The source is useful in my research.
Reflect: I will be useing in my slideshow presentation.
 Cartoon about stem cell research and congress. 2011. Photo Google Scholar Images
http://www.thestemcellblog.com/wp-content/uploads/2011/01/stem_cells_cartoon.jpg
Summary: The image is a good reflection of my content.
Ascess: The source corisponds to my wrinings in my slideshow
Reflect: I will be useing in my slideshow



Sofia Ambrosia, 2011. Photo Google scholar
https://s3.amazonaws.com/healthtap-public/ht-staging/user_answer/reference_image/4275/large/Stem_Cells.jpeg?1349189886
Summary:The Image gives good visualation in regards to my content.
Ascess : The image gives my viewer a more relationship with my slideshow
Reflect: I will be useing this image in my slideshow

Tuesday, December 4, 2012

Slide show


Wednesday, October 31, 2012

slide show

My Idea for the slide show would be to first show some of the different stem cells and focus on the diseases. I would show the pictures of the diseases if at all possible and show some of the stages that occurr when there is no possible cure. I would also show the differnt surgerys performed when harvesting the different types of stem cells. I would try to  show pictures of reasearch projects that are currently going on to dipict the hours scientist put into the cure for each individual patient. I would also emphise how much of schooling each scientist has to go threw to get to be a reasearcher in a stem cell project. This would show that there is muck knowledge going into completeing the project themselves. I may even place some charts with stats showing the cures deaths and possible side effect deaths or worse out comes so that the patients can visually see both sides of the so called coin. I would also possibly show images of the scientist if I have or find. I would also maybe show at what stage would work best for the treatment to work opposed to being so far gone. Although some reasearchers need patients that are in different stages so that hopefilly they would be able to provide a cure for them then.







Posted by lisa f at 8:57 AM No comments:

Sunday, December 2, 2012

interview

  • What do I still need to know about my topic to successfully support my main idea? I need to gather more information so that I could take a new direction of thought. More toward the science aspect of stem cells.
  • Who might be able to offer me that information in an interview? I believe either a hospital or a college who is currently in a reaseach project or clinical trial.
  • Why would that person be considered an expert in the field? Dr lucy godley. because she is currenly running a clinical trial at the university of chicaho Medicine.
  • What 3 questions can I ask this expert to  elicit the information I need to support my main idea in the webtext?What is your position and what is your day to day job? Is the same issue focused on each day? What is required from you as far as the scientific side? What is the difference in all of the types of stem cells you research by this I mean how you contain and keep them preserved for the scientific portion? Can a patient start noticing the effects of a successful stem cell Transplant right away or is there a length of time before you will know if it took?
  • What is my next step to accomplish this field research? The next step would be to contact Lucy and see when would be a good time for her.

Interview protical


interview protical
Protocol



Stem cells and trials

1.     I will talk to someone who is a scientist who is working a clinical trial where stem cells are being studied.

2.     I will conduct this interview either via email or on the phone.

3.     My goal is to learn the effects on the stem cells themselves and what happens in the process of the trials on the scientific side.

4.     I will conduct this interview in formal and professional manner.

5.     I want to learn the effects on the study of the stem cells themselves and if all of the cells are used in the process and what happens in each step of the process.

6.     I want to learn from both a scientific and personal view on the stem cells studies exactly what ones are most productive in slowing or preventing which diseases.

7.     I want to know there stand on the issue as far as the laws and guide lines of clinical stem cells.



Contact information:

Dr. Lucy Godley

The University of Chicago Medicine
5841 S. Maryland Avenue
Chicago, IL 60637 | 773-702-1000



Questions:



What is your position and what is your day to day job? Is the same issue focused on each day? What is required from you as far as the scientific side?



What is the difference in all of the types of stem cells you research by this I mean how you contain and keep them preserved for the scientific portion?



Can a patient start noticing the effects of a successful stem cell Transplant right away or is there a length of time before you will know if it took?



In your opinion why is there so much controversy on embryonic and not so much on other types of stem cells when it comes to clinical trials?



Are there any cells that you notice right on harvesting or testing that you know will not work and how is it that you know this?



What happens in the trials with the funding when there aren’t enough patients for the trial?



Who makes for a healthy patient in harvesting the stem cells? Where do you most likely focus your retrieval from when cells are needed as far as family or random donors?



What does a dr or scientist go through when the transplants are not successful? Do you hold a meeting and try to find out where complications may have occurred or do you just chalk it up to the body just rejected it without further thought?


Wednesday, October 10, 2012

An Annotation and bibliographic entry

In the article it revels that they discovered that "embryonic stem cells express large proportions of their genome ( Hebrew University,2008)" by this they have discovered that tissues have specific genes. It is believed that because of this specific gene sequencing it unlocks their secrets to how they function and develop. But once this is gone the ability to understand goes with it. But at that point embryonic stells stand by attentively waiting to transform into what ever tissue the body calls on for it's need.


The Hebrew University of Jerusalem (2008, May 13). How Embryonic Stem Cells Develop Into Tissue-specific Cells Demonstrated. Retrieved from: http://www.sciencedaily.com/releases/2008/05/080512105729.htm



John B. Gurdon and Shinya Yamanaka have been recognised for discovering that embryonic stem cells can change into any tissue types in the human body and how they develop. Because of their studies they changed mature cells into reprogramming and becoming pluripotent stem cells. Because of these discoveries scientist changed there whole out look on disease study and new methods for diagnosing and developing cures medicine etc.



Nobel Foundation (2012, October 8). Nobel Prize in Physiology or Medicine 2012 awarded for discovery that mature cells can be. Retrieved from: http://www.sciencedaily.com/releases/2012/10/121008082955.htm


Monday, October 8, 2012

Midterm

Some of the issues I have related to my webtext is that although I do know a lot about computers I am not computer savy. I have had a few issues when it comes to researching some of my subject material in google scholars only because some of them want you to purchase the material prior to reading the whole piece. Another issue that I have encountered is the way to word specific issues without becoming too repetitive or boring to say the least. I find that some of my writing may be below that of scholorly at least this is my own personal opinion as far as how I would like the reader to understand and get the importance of my work. It has become hard to guide my threw the understanding of the fonts, them change and how to make the lay out how I would like it. I recently have seeked helped for this and have somewhat of a better understanding now. In my disscussion posts for this class they seem to be very helpful in relating to my webtext and be used as examples of work that needed to be placed the web text. I enjoy the writhing journals so far because it helps with gathering ideas on topics and different ideas. I am over coming these issues by going to the wring lab and emailing peers to proof read and rereading my material as often as possible.

Wednesday, October 3, 2012

pod


Stem cells have several different applications in basic research, drug discovery, and cell therapy. In basic research applications stem cells improve the ability to screen for side effects in many different drugs. Because of the use of stem cells at the beginning of the screenings of drugs there will be a lesser over head cost as well as the ability to scrap drugs that are extremely harmful or fatal. Because under current government standards animals are used to take the drugs and because of this the outcomes are different slightly because humans are made up of different cells and organelles the side effects on animals may not have none at all opposed to people. Because stem cells can regenerate and create new tissues the ability to create different organs to use to test on such as the heart or liver because of the harmful effects it had on individuals when they are administered powerful drugs. This would take medical science and drug researchers to a safer drug administered program for humans. This would mean that if the cells had high toxicity of drugs then they would not be available for clinical trials and the patients who are receiving them would go through fewer side effects. This would mean a cure possibly for tumors in embryonic stem cell research. Companies would be able to manufacture drugs that would be made for each independent trial instead of groups and finding out that fatal side effects occurred because of the risks to the patients.